Werewolf Therapeutics, Inc. closed fiscal year 2025 with $69.4M in total assets, $44.6M in total liabilities and $24.8M in shareholder equity. Total assets fell 45.3% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Werewolf Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
HOWL Balance Sheet by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
HOWL Balance Sheet by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'25S-4/A | Q3'2510-Q | Q2'2510-Q | Q1'25Filing | Q4'2410-K | Q3'2410-Q | Q2'24Filing | Q1'24Filing | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $42.8M-46.3% | $24.2M-73.9% | $58.0M-45.9% | $69.4M-45.3% | $79.6M-43.1% | $92.6M-39.8% | $107.2M-39.6% | $126.9M-27.4% | $140.0M-20.6% | $153.7M-17.0% | $177.6M-9.0% | $174.8M+9.1% |
| Total Liabilities | $36.0M-28.0% | $7.9M-84.6% | $45.8M-8.2% | $44.6M-16.7% | $50.0M-1.3% | $51.1M+2.9% | $49.9M-16.8% | $53.5M-15.6% | $50.7M-20.8% | $49.7M-25.4% | $60.0M-18.9% | $63.5M+67.4% |
| Total Equity | $6.8M-77.2% | $16.3M-60.7% | $12.2M-78.7% | $24.8M-66.2% | $29.6M-66.9% | $41.5M-60.1% | $57.3M-51.3% | $73.4M-34.1% | $89.4M-20.5% | $104.0M-12.3% | $117.6M-2.9% | $111.4M-9.0% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Werewolf Therapeutics, Inc. financials
Frequently Asked Questions
Werewolf Therapeutics, Inc. closed fiscal year 2025 with $69.4M in total assets, $44.6M in total liabilities and $24.8M in shareholder equity.
Werewolf Therapeutics, Inc. (HOWL) total assets fell by 45.3% year over year, from $126.9M to $69.4M in fiscal year 2025.
Across the 6 fiscal years this page covers, Werewolf Therapeutics, Inc. (HOWL) total assets went from $96.4M in fiscal year 2020 to $69.4M in fiscal year 2025.
Werewolf Therapeutics, Inc. (HOWL) reported $42.8M in total assets in Q3 2026. This represents a decrease of 46.3% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Werewolf Therapeutics, Inc. (HOWL) reported on that line in every period on record.